|

Transdiagnostic Cognitive Biomarkers

RECRUITINGN/ASponsored by University of Minnesota
Actively Recruiting
PhaseN/A
SponsorUniversity of Minnesota
Started2022-04-11
Est. completion2026-03-01
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →

NCT04864080

Summary

The overall objective of this study is to determine the feasibility of identifying transdiagnostic biomarkers of cognitive function mediated by neuromodulation of the dorsolateral prefrontal cortex that are translatable across disease groups in order to more accurately phenotype clusters of cognitive dysfunction. Completing behavioral paradigms with electrophysiology and TMS is a challenging frontier. This study focuses on the feasibility of such an endeavor for those with chronic pain or depression as well as healthy controls.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Arm 1, healthy controls:

Inclusion Criteria:

* Have access to the online study platform.

Exclusion Criteria:

* under 18, non-English speaking

Arm 2: pain and depression:

Inclusion Criteria:

* Pain or depression

Exclusion Criteria:

* pregnant women

Conditions2

DepressionPain

Locations1 site

University of Minnesota
Minneapolis, Minnesota, 55455
David Darrow612-946-1424hdlab@umn.edu

Browse More Trials

Depression trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.